Stay updated on HMPL-813 in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the HMPL-813 in Glioblastoma Clinical Trial page.

Latest updates to the HMPL-813 in Glioblastoma Clinical Trial page
- Check4 days agoChange DetectedLocations are consolidated under a single 'Locations' section listing Shanghai Municipality and Zhejiang, replacing the previous separate site entries; the 'HHS Vulnerability Disclosure' link was removed and the revision updated to v3.3.3.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 update applied; no user-facing changes to study details or navigation.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding lapse notice from the page; no other core trial information changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedThe new screenshot shows the same study details with updated styling and layout; no changes to core content such as inclusion criteria, interventions, primary outcomes, or enrollment were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference6%

- Check90 days agoChange DetectedUpdated contact information and updated software version from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to HMPL-813 in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-813 in Glioblastoma Clinical Trial page.